Clinical trial
Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
NCT05374928 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 9, 2020
- Completion date
- June 1, 2026
- Enrollment
- 316 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic generalized epilepsy